Chemo Triplet May Boost Survival in Rare Soft-Tissue Sarcoma

(MedPage Today) -- Adding temozolomide to a combination of vincristine and irinotecan (VIT) improved tumor response and survival in patients with relapsed or refractory rhabdomyosarcoma in a European phase II trial.
In the trial of over 100 patients...